Skip to main content
FDA clears GenMark's gram-negative diagnostic panel
4/16/2019

The FDA has granted GenMark Diagnostics 510(k) clearance for its ePlex Blood Culture Identification Gram-Negative Panel, which is designed to detect bloodstream infections that can lead to sepsis. The device is the third ePlex BCID panel from GenMark to secure FDA clearance during the past four months.

Full Story: